scholarly journals Neuro-immune interactions in chemical-induced airway hyperreactivity

2016 ◽  
Vol 48 (2) ◽  
pp. 380-392 ◽  
Author(s):  
Fien C. Devos ◽  
Brett Boonen ◽  
Yeranddy A. Alpizar ◽  
Tania Maes ◽  
Valérie Hox ◽  
...  

Asthma may be induced by chemical sensitisers,viamechanisms that are still poorly understood. This type of asthma is characterised by airway hyperreactivity (AHR) and little airway inflammation. Since potent chemical sensitisers, such as toluene-2,4-diisocyanate (TDI), are also sensory irritants, it is suggested that chemical-induced asthma relies on neuro-immune mechanisms.We investigated the involvement of transient receptor potential channels (TRP) A1 and V1, major chemosensors in the airways, and mast cells, known for their ability to communicate with sensory nerves, in chemical-induced AHR.In vitrointracellular calcium imaging and patch-clamp recordings in TRPA1- and TRPV1-expressing Chinese hamster ovarian cells showed that TDI activates murine TRPA1, but not TRPV1. Using anin vivomodel, in which an airway challenge with TDI induces AHR in TDI-sensitised C57Bl/6 mice, we demonstrated that AHR does not develop, despite successful sensitisation, inTrpa1andTrpv1knockout mice, and wild-type mice pretreated with a TRPA1 blocker or a substance P receptor antagonist. TDI-induced AHR was also abolished in mast cell deficientKitWsh/Wshmice, and in wild-type mice pretreated with the mast cell stabiliser ketotifen, without changes in immunological parameters.These data demonstrate that TRPA1, TRPV1 and mast cells play an indispensable role in the development of TDI-elicited AHR.

Blood ◽  
2004 ◽  
Vol 104 (11) ◽  
pp. 1707-1707
Author(s):  
Giovanni Migliaccio ◽  
Barbara Ghinassi ◽  
Lucia Centurione ◽  
Maria Zingariello ◽  
Lucia Bianchi ◽  
...  

Abstract Megakaryocytopoiesis is regulated by extrinsic (interaction of the growth factor thrombopoietin, TPO with its receptor Mpl) and intrinsic (interaction between the trascription factors GATA-1 and Fog-1) factors. The observation that mice impaired for GATA-1 expression (i.e. harbouring the GATA-1low mutation) are defective not only in megakaryocyte maturation but also in mast cell differentiation (Migliaccio et al. J Exp Med197:281, 2003), led us to investigate whether TPO might control mast cell differentiation as well. We first observed that mice genetically unable to responde to TPO (Mplnull mice) express in the connective tissues 5 times more mast cells than their normal littermates. Then, we analysed the effects on mast cell differentiation of in vivo treatment with TPO. Normal mice, and their GATA-1low littermates, were injected i.p. with TPO (100 μg/kg/day per 5 days, kindly provided by Kirin Brewery, Japan) and the number of immature (Toluidinepos) and mature (AlcianBlue/Saphraninepos) mast cells present in the connective tissues of the animals, as well as the frequency of GATA-1pos and TUNELpos mast cells, was evaluated 14 days after treatment. In wild-type animals, TPO reduced the presence of GATA-1 in mast cells (by immuno-histochemistry) and increased the number of immature cells (from 320±28 to 852±60) and of those undergoing apoptosis (from 16±1 to 600±43). In contrast, in GATA-1low animals, TPO-treatment induced the expression of GATA-1 in mast cells while decreased the number of immature cells (from 1100±72 to 427±29) as well as that of apoptotic cells (from 600±45 to 60±2). The role of TPO on mast cell differentiation were further confirmed by the analysis of the effects exerted by the growth factor on in vitro differentiation of bone marrow derived mast cells (BMMC). In these experiments, wild type bone marrow and spleen cells were cultured for 21 days with SCF and IL-3 with or without TPO and BMMC differentiation measured on the basis of the number of cells expressing the phenotype c-kithigh/CD34high and FcεRIpos. In cultures stimulated with SCF and IL-3, all the cells expressed the phenotype c-kithigh/CD34high and FcεRIpos. In contrast, in cultures supplemented also with SCF, IL-3 and TPO, only 25% of the cells were c-kithigh/CD34high and none of them was FcεRIpos. These results establish a role for TPO in the control of mast cell differentiation (possibly by modulating the GATA-1 content of the cells) and unveil further similarities between the mechanism(s) controlling megakaryocyte and mast cell differentiation.


2020 ◽  
Author(s):  
Ruhui Yang ◽  
Guangli Wang ◽  
Lingyun Li ◽  
Hanjiang He ◽  
Mingzhu Zheng ◽  
...  

Abstract Background: Thymocyte-expressed, positive selection-associated 1 (Tespa1) is a critical signaling molecule in thymocyte development. This study aimed to investigate the regulatory effect of Tespa1 on mast cells in the pathogenesis of asthma and its relationship with the interleukin (IL)-4 /signal transducers and activators of transcription 6 (STAT6) signaling pathway.Methods: Tespa1 mRNA expression analysis and IgE levels were carried out using the induced sputum of 33 adults with stable asthma and 36 healthy controls. Tespa1-knockout mice (Tespa1-/-, KO) and C57BL/6 background (wild-type, WT) mice were sensitized and treated with ovalbumin (OVA) to establish an asthma model. Pathological changes, number and activity of mast cells, and changes in activation of the IL-4 /STAT6 pathway in lung tissue were detected. The changes of tryptase expression and STAT6 activation after mast cell gene knockout were analyzed in vitro. The changes of enzyme expression and STAT6 activation after mast cell gene knockout were analyzed in vitro. The association between the Tespa1 and p-STAT6 was analyzed by co-immunoprecipitation method.Results: Compared with the healthy controls, Tespa1 expression was decreased, and IgE levels were elevated in the sputum of asthmatic patients. Animal experiments showed that Tespa1-/- mice exhibited more severe inflammation, higher quantity of goblet cells and mast cells in the bronchium, and greater expression of mast cell tryptase, which is induced by ovalbumin, than WT mice. And IL-4, IL-13, phospho-Janus kinase 1, and p-STAT6 expressions presented a higher increase in the Tespa1-/- mouse model than in the WT mouse model. Further in vitro studies confirmed that IL-4 could more significantly promote tryptase and p-STAT6 activities in Tespa1-/- mast cells than their WT counterparts. Correlation analysis results showed a negative correlation between Tespa1 and p-STAT6. Co-immunoprecipitation results demonstrated an association between Tespa1 and p-STAT6.Conclusions: Altogether, our results indicate that Tespa1 can negatively regulate mast cell activity, and this event is related to the mast cell IL-4/STAT6 signaling pathway and could be therapeutically exploited to treat asthma attacks.


2011 ◽  
Vol 2011 ◽  
pp. 1-9 ◽  
Author(s):  
Rodrigo Orlandini de Castro

The protein tyrosine kinase Syk plays a critical role in FcεRI signaling in mast cells. Binding of Syk to phosphorylated immunoreceptor tyrosine-based activation motifs (p-ITAM) of the receptor subunits results in conformational changes and tyrosine phosphorylation at multiple sites that leads to activation of Syk. The phosphorylated tyrosines throughout the molecule play an important role in the regulation of Syk-mediated signaling. Reconstitution of receptor-mediated signaling in Syk-/- cells by wild-type Syk or mutants which have substitution of these tyrosines with phenylalanine together with in vitro assays has been useful strategies to understand the regulation and function of Syk.


2007 ◽  
Vol 292 (4) ◽  
pp. H1821-H1827 ◽  
Author(s):  
Tine V. Karlsen ◽  
Athanasia Bletsa ◽  
Eli-Anne B. Gjerde ◽  
Rolf K. Reed

Neurogenic inflammation is known to induce lowering of interstitial fluid pressure (Pif) in mouse skin. This study examined the possible role of mast cell activation secondary to neuropeptide release in lowering of Pifby using KitW/ KitW-vmice, which are devoid of mast cells, including connective tissue mast cells (CTMCs). Pifwas measured in paw skin of anesthetized (fentanyl-fluanison and midazolam, 1:1) mice with glass capillaries connected to a servo-controlled counterpressure system. In contrast to wild-type mice, intravenous administration of mast cell-activating compound 48/80 induced no lowering of Pifin KitW/ KitW-vmice. Intravenous challenge with substance P (SP), calcitonin gene-related peptide (CGRP), or capsaicin induced a significant ( P < 0.05) lowering of Pifin wild-type mice to −2.16 ± 0.28, −1.96 ± 0.11, and −2.22 ± 0.19 mmHg, respectively, compared with vehicle (−0.49 ± 0.11 mmHg). In KitW/ KitW-vmice the Pifresponse to SP was completely abolished (−0.53 ± 0.32 mmHg) while the response to CGRP and capsaicin was attenuated (−1.33 ± 0.13 and −1.42 ± 0.13 mmHg, respectively) although significantly ( P < 0.05) lowered compared with vehicle. Immunohistochemical analysis revealed no difference in distribution or density of SP- and CGRP-immunoreactive fibers in paws of KitW/ KitW-vcompared with wild-type mice. We conclude that lowering of Pifnormally depends on mast cells. However, the sensory nerves can also elicit a lowering of Pifthat is independent of mast cells.


2012 ◽  
Vol 303 (6) ◽  
pp. L539-L549 ◽  
Author(s):  
Eda Yildirim ◽  
Michelle A. Carey ◽  
Jeffrey W. Card ◽  
Alexander Dietrich ◽  
Gordon P. Flake ◽  
...  

Transient receptor potential channels (TRPCs) are widely expressed and regulate Ca2+entry in the cells that participate in the pathophysiology of airway hyperreactivity, inflammation, and remodeling. In vitro studies point to a role for TRPC1-mediated Ca2+signaling in several of these cell types; however, physiological evidence is lacking. Here we identify TRPC1 signaling as proinflammatory and a regulator of lung hyperresponsiveness during allergen-induced pulmonary response. TRPC1-deficient ( Trpc1−/−) mice are hyposensitive to methacholine challenge and have significantly reduced allergen-induced pulmonary leukocyte infiltration coupled with an attenuated T helper type 2 (Th2) cell response. Upon in vitro allergen exposure, Trpc1−/−splenocytes show impaired proliferation and T cell receptor-induced IL-2 production. A high number of germinal centers in spleens of Trpc1−/−mice and elevated levels of immunoglobulins in their serum are indicative of dysregulated B cell function and homeostasis. Thus we propose that TRPC1 signaling is necessary in lymphocyte biology and in regulation of allergen-induced lung hyperresponsiveness, making TRPC1 a potential target for treatment of immune diseases and asthma.


2020 ◽  
Vol 18 (1) ◽  
Author(s):  
Ruhui Yang ◽  
Guangli Wang ◽  
Lingyun Li ◽  
Hanjiang He ◽  
Mingzhu Zheng ◽  
...  

Abstract Background Thymocyte-expressed, positive selection-associated 1 (Tespa1) is a critical signaling molecule in thymocyte development. This study aimed to investigate the regulatory effect of Tespa1 on mast cells in the pathogenesis of asthma and its relationship with the interleukin (IL)-4/signal transducers and activators of transcription 6 (STAT6) signaling pathway. Methods Tespa1 mRNA expression analysis and IgE levels were carried out using the induced sputum of 33 adults with stable asthma and 36 healthy controls. Tespa1-knockout mice (Tespa1−/−, KO) and C57BL/6 background (wild-type, WT) mice were sensitized and treated with ovalbumin (OVA) to establish an asthma model. Pathological changes, number and activity of mast cells, and changes in activation of the IL-4/STAT6 pathway in lung tissue were detected. The changes of tryptase expression and STAT6 activation after mast cell gene knockout were analyzed in vitro. The changes of enzyme expression and STAT6 activation after mast cell gene knockout were analyzed in vitro. The association between the Tespa1 and p-STAT6 was analyzed by co-immunoprecipitation method. Results Compared with the healthy controls, Tespa1 expression was decreased, and IgE levels were elevated in the sputum of asthmatic patients. Animal experiments showed that Tespa1−/− mice exhibited more severe inflammation, higher quantity of goblet cells and mast cells in the bronchium, and greater expression of mast cell tryptase, which is induced by ovalbumin, than WT mice. And IL-4, IL-13, phospho-Janus kinase 1, and p-STAT6 expressions presented a higher increase in the Tespa1−/− mouse model than in the WT mouse model. Further in vitro studies confirmed that IL-4 could more significantly promote tryptase and p-STAT6 activities in Tespa1−/− mast cells than their WT counterparts. Correlation analysis results showed a negative correlation between Tespa1 and p-STAT6. Co-immunoprecipitation results demonstrated an association between Tespa1 and p-STAT6. Conclusions Altogether, our results indicate that Tespa1 can negatively regulate mast cell activity, and this event is related to the mast cell IL-4/STAT6 signaling pathway and could be therapeutically exploited to treat asthma attacks.


2020 ◽  
Author(s):  
Ruhui Yang ◽  
Guangli Wang ◽  
Lingyun Li ◽  
Hanjiang He ◽  
Mingzhu Zheng ◽  
...  

Abstract Background: Thymocyte-expressed, positive selection-associated 1 (Tespa1) is a critical signaling molecule in thymocyte development. This study aimed to investigate the regulatory effect of Tespa1 on mast cells in the pathogenesis of asthma and its relationship with the interleukin (IL)-4 /signal transducers and activators of transcription 6 (STAT6) signaling pathway.Methods: Tespa1 mRNA expression analysis and IgE levels were carried out using the induced sputum of 33 adults with stable asthma and 36 healthy controls. Tespa1- knockout mice ( Tespa1 -/- , KO) and C57BL/6 background (wild-type, WT) mice were sensitized and treated with ovalbumin (OVA) to establish an asthma model. Pathological changes, number and activity of mast cells, and changes in activation of the IL-4 /STAT6 pathway in lung tissue were detected. The changes of tryptase expression and STAT6 activation after mast cell gene knockout were analyzed in vitro . The changes of enzyme activation and STAT6 activation after mast cell gene knockout were analyzed in vitro . The association between the Tespa1 and p-STAT6 was analyzed by co-immunoprecipitation method.Results: Compared with the healthy controls, Tespa1 expression was decreased, and IgE levels were elevated in the sputum of asthmatic patients. Animal experiments showed that Tespa1 -/- mice exhibited more severe inflammation, higher quantity of goblet cells and mast cells in the bronchium, and greater activity of mast cell tryptase, which is induced by ovalbumin, than WT mice. And IL-4, IL-13, phospho-Janus kinase 1, and p-STAT6 expressions presented a higher increase in the Tespa1 -/- mouse model than in the WT mouse model. Further in vitro studies confirmed that IL-4 could more significantly promote tryptase and p-STAT6 activities in Tespa1 -/- mast cells than their WT counterparts. Correlation analysis results showed a negative correlation between Tespa1 and p-STAT6. Co-immunoprecipitation results demonstrated an association between Tespa1 and p-STAT6.Conclusions: Altogether, our results indicate that Tespa1 can negatively regulate mast cell activity, and this event is related to the mast cell IL-4/STAT6 signaling pathway and could be therapeutically exploited to treat asthma attacks.


Blood ◽  
2004 ◽  
Vol 104 (11) ◽  
pp. 815-815
Author(s):  
Kevin D. Bunting ◽  
Christine Couldrey ◽  
Richard Moriggl ◽  
Yongzhi Cui ◽  
Harry Wright ◽  
...  

Abstract Signal transducer and activator of transcription (STAT5) has important functions in hematopoiesis. Our prior work with mice in which two coding exons of STAT5a and STAT5b have been deleted (STAT5ab−/−) has shown that mast cells derived in the presence of interleukin(IL)-3 and stem cell factor (SCF) have severe defects in survival and proliferation (Shelburne et al. Blood102:1290; 2002). However, the mechanism for STAT5 activation by SCF is unclear. In erythroid cells, STAT5 is not tyrosine phosphorylated by SCF alone. We have set out to determine whether some SCF-induced functions of STAT5 could be rescued in c-Kit+Fcγ+ primary bone marrow (BM) or fetal liver (FL) derived mast cell cultures from STAT5ab−/− mice. STAT5ab−/− mouse mast cells had a normal chemotactic response to SCF compared with wild-type mast cells, however we found they highly expressed N-terminal truncated STAT5 isoforms (STAT5ΔN) from position 102 and 136. In contrast, expression of STAT5ΔN in wild-type mast cells and some STAT5ab−/− tissues such as spleen and brain was barely detectable. While naturally occuring C-terminal STAT5 variants bind DNA but do not transactivate target genes, N-terminal variants of STAT5 have defective tetramerization. Generally, the N-terminus of STATs is also believed essential for function. Therefore, we have used mast cells to test whether N-terminal STAT5 mutants (STAT5ΔN1–136 or STAT5W37A) could functionally restore previously reported defects in vitro. Both of the STAT5 mutants were found to be dimerization-competent but tetramerization-deficient. MSCV-based retroviral vectors expressing these STAT5 mutants upstream of IRES-GFP were stably transduced into STAT5ab−/− mast cells. A strong selective advantage for GFP+ cells was observed for all vectors containing STAT5wt, STAT5ΔN, or STAT5W37A but not for IRES-GFP control. Inversely, in wild-type mast cells, only the STAT5ΔN mutant conferred a selective advantage, suggesting that the heterodimer (ΔN/wt) between STAT5ΔN and STAT5wt was most active. In apoptosis experiments, STAT5ΔN protected following cytokine withdrawal. We found the homodimer (ΔN/ΔN) to be intermediate in terms of growth reconstitution potential than the heterodimer. However, retroviral overexpression of the homodimer above that of the endogenous STAT5ΔN alone was sufficient to correct growth defects. To further explore the role of the endogenous STAT5ΔN, we obtained FL-derived mast cells from a new STAT5null/null mouse where the entire STAT5ab locus was deleted using the Cre-LoxP system (Cui et al. MCB, in press). These mast cells lacked STAT5 and STAT5ΔN. Unlike the STAT5ab−/− mast cells, the STAT5null/null mast cells showed a 9-fold reduction in SCF-induced chemotaxis relative to wild-type controls. Importantly, the chemotactic defects were completely rescued by gene transfer of wild-type STAT5a (P=0.018) or STAT5ΔN (P=0.02) relative to IRGFP control. Therefore, 1) endogenous STAT5ΔN is active but to a different degree depending on the specific function and cell type 2) co-expression along with full-length STAT5 confers maximal SCF-mediated responsiveness in mast cells. This work uncovers a potential mechanism by which STAT5-mediated SCF responses are regulated via formation of functional heterodimers.


2010 ◽  
Vol 207 (3) ◽  
pp. 455-463 ◽  
Author(s):  
Lisa Biggs ◽  
Chunping Yu ◽  
Boris Fedoric ◽  
Angel F. Lopez ◽  
Stephen J. Galli ◽  
...  

Mast cell production of interleukin-10 (IL-10) can limit the skin pathology induced by chronic low-dose ultraviolet (UV)-B irradiation. Although the mechanism that promotes mast cell IL-10 production in this setting is unknown, exposure of the skin to UVB irradiation induces increased production of the immune modifying agent 1α,25-dihydroxyvitamin D3 (1α,25[OH]2D3). We now show that 1α,25(OH)2D3 can up-regulate IL-10 mRNA expression and induce IL-10 secretion in mouse mast cells in vitro. To investigate the roles of 1α,25(OH)2D3 and mast cell vitamin D receptor (VDR) expression in chronically UVB-irradiated skin in vivo, we engrafted the skin of genetically mast cell–deficient WBB6F1-KitW/W-v mice with bone marrow–derived cultured mast cells derived from C57BL/6 wild-type or VDR−/− mice. Optimal mast cell–dependent suppression of the inflammation, local production of proinflammatory cytokines, epidermal hyperplasia, and epidermal ulceration associated with chronic UVB irradiation of the skin in KitW/W-v mice required expression of VDR by the adoptively transferred mast cells. Our findings suggest that 1α,25(OH)2D3/VDR-dependent induction of IL-10 production by cutaneous mast cells can contribute to the mast cell’s ability to suppress inflammation and skin pathology at sites of chronic UVB irradiation.


Author(s):  
E.Y. Chi ◽  
M.L. Su ◽  
Y.T. Tien ◽  
W.R. Henderson

Recent attention has been directed to the interaction of the nerve and immune systems. The neuropeptide substance P, a tachykinnin which is a neurotransmitter in the central and peripheral nervous systems produces tissue swelling, augemntation of intersitial fibrin deposition and leukocyte infiltration after intracutaneous injection. There is a direct correlation reported between the extent of mast cell degranulation at the sites of injection and the tissue swelling or granulocyte infiltration. It has previously been demonstrated that antidromic electrical stimulation of sensory nerves induces degranulation of cutaneous mast cells, cutaneous vasodilation and augmented vascular permeability. Morphological studies have documented a close anatiomical association between mast cells and nonmyelinated nerves, that contain substance P and other neuropeptides. However, the presence of mast cells within nerve fasicles has not been previously examined ultrastructurally. In this study, we examined ultrastructurally the distribution of mast cells in the nerve fiber bundles located in the muscular connective tissue of rat tongues (n=20).


Sign in / Sign up

Export Citation Format

Share Document